Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study.
Sleep drugs are often necessary to treat insomnia in older patients. Benzodiazepine receptor agonists (BZRAs) are primarily used for insomnia in these patients, but there are concerns regarding their association with delirium and bone fractures. Among sleep drugs, orexin receptor antagonists such as...
Main Authors: | Ryozo Yoshioka, Seiichiro Yamamoto, Eiji Nakatani |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0284726 |
Similar Items
-
Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
by: Ryozo Yoshioka, et al.
Published: (2023-01-01) -
Treatment of sleep‐related eating disorder with suvorexant: A case report on the potential benefits of replacing benzodiazepines with orexin receptor antagonists
by: Kentaro Matsui, et al.
Published: (2023-09-01) -
Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists
by: Kensuke Usui, et al.
Published: (2023-06-01) -
Suvorexant, a Novel Dual Orexin Receptor Antagonist, for the Management of Insomnia
by: Andrew H. Han, et al.
Published: (2023-01-01) -
Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study
by: François-Xavier Sibille, et al.
Published: (2022-02-01)